Michael J. Purcell

Filings by Michael J. Purcell span 3 companies, the busiest being International Money Express, Inc., Tabula Rasa HealthCare, Inc. and Hepion Pharmaceuticals, Inc. Between 11 June 2021 and 1 October 2026, the trades on record add up to 38 filings.

The open-market side counts 5 purchases for €511k alongside 1 sale for €40k. Purchases outweigh sales by €470k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 31 share grants. Since January 2026: 2 purchases and no sales on the market.

A typical purchase (the median) is worth €87k. Clusters matter here: 4 out of 5 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 2 October 2026 came the latest disclosure, a share grant for €14k in International Money Express, Inc. The most recent open-market purchase was published on 12 August 2026, 67 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.